 impair lipopolysaccharide-induc tumor necrosi factor product vitro peripher blood monocyt patient viral hepat lipopolysaccharide-induc tumor necrosi factor product vitro peripher blood monocyt patient variou liver diseas tumor necrosi factor product patient chronic hepat pg tumor necrosi factor/ml mean s.e.m patient chronic non-a non-b hepat pg tumor necrosi factor/ml healthi control individu pg tumor necrosi factor/ml reduc tumor necrosi factor product optim stimul concentr lipopolysaccharid ng/ml suboptim concentr ng/ml contrast patient chronic viral hepat monocyt patient alcohol-induc cirrhosi pg tumor necrosi factor/ml primari biliari cirrhosi pg tumor necrosi factor/ml alcohol-induc fatti liver chang pg tumor necrosi factor/ml normal amount tumor necrosi factor optim concentr lipopolysaccharid lipopolysaccharid lipopolysaccharide/ml peripher blood monocyt patient chronic hepat pg/ml non-a non-b hepat pg/ml tumor necrosi factor gamma-interferon pg/ml pg/ml lymphokin monocyt cyclooxygenas inhibitor indomethacin suppress effect prostaglandin pg/ml pg/ml